Bills › 2025-26
ESSB 5916: Nonopioid drugs for pain
Data last updated: bill actions through Aug 23, 2026 · lobbyist reports through Sep 30, 2026 (read Oct 14, 2026)
Concerning nonopioid drugs for the treatment of pain.
- Prime sponsor
- Paul Harris
- Introduced
- Jan 27, 2026
- Status
- By resolution, returned to Senate Rules Committee for third reading. (Mar 12, 2026)
- The Legislature's page
- ESSB 5916 on leg.wa.gov
Floor votes
No floor roll call on file (it didn't pass a chamber, or it was decided without one).
Who lobbied on it 4
| Employer | Lobbyists | To 2026 candidates |
|---|---|---|
| Association of Washington Healthcare Plans | 2 | — |
| VERTEX PHARMACEUTICALS INC | 2 | — |
| CONSUMER HEALTHCARE PRODUCTS ASSN | 1 | — |
| Prime Therapeutics, LLC | 1 | — |
Lobbying reports name a bill number, not a position on it or a version of it. Money: what each employer (as a donor to two or more 2026 candidates) gave to the 2026 campaigns of the members who voted yea or nay on the bill's latest final passage in each chamber.